Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats

Molecular and Cellular Neuroscience

Volumn 16, Issue 5, 2000, Pages 542-556

  Hinks, G L ^a   Franklin, R J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GENE PRODUCT; GROWTH FACTOR; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; PROTEIN GGF 2; PROTEIN NT 3; SCAVENGER; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DEMYELINATION; FEMALE; GENE EXPRESSION; IN SITU HYBRIDIZATION; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; REMYELINIZATION; SPINAL CORD; STEM CELL; SURVIVAL TIME;

EID: 0034530520     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2000.0897     Document Type: Article

References (62)

1. Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain
2. Insulin-like growth factor I in cultured rat astrocytes: Expression of the gene, and receptor tyrosine kinase
3. Synthesis of basic fibroblast growth factor upon differentiation of rat mammary epithelial to myoepithelial-like cells in culture
4. IGF-1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons
5. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis
6. Developmental regulation of myelin basic protein expression in mouse brain
7. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice
8. Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment
9. Temporal analysis of growth factor mRNA expression in myelinating rat brain aggregate cultures: Increments in CNTF, FGF-2, IGF-I and PDGF-AA mRNA are induced by antibody-mediated demyelination
10. Molecular profile of reactive astrocytes: Implications for their role in neurologic disease
11. TGF-βl is an organizer of responses to neurodegeneration
12. Understanding CNS remyelination: Clues from developmental and regeneration biology
13. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats
14. In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system
15. Delayed remyelination in the rat spinal cord following ethidium bromide injection
16. Protein growth factors as potential therapies for central nervous system demyelinative disorders
17. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36
18. Distinctive patterns of PDGF-A, FGF-2, IGF-I and TGF-β1 gene expression during remyelination of experimentally-induced spinal cord demyelination
19. Prominent expression of bFGF in dorsal root ganglia after axotomy
20. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination
21. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination
22. Transforming growth factor-beta 1 in the rat brain: Increase after injury and inhibition of astrocyte proliferation
23. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune allergic encephalomyelitis
24. Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS
25. Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages
26. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis
27. Chronic demyelination inhibits remyelination in the central nervous system
28. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system
29. Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains
30. The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS
31. Trapidil-mediated growth factor-inhibition during CNS remyelination results in reduced numbers of oligodendrocytes
32. A role for TGF-β in oligodendrocyte differentiation
33. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro
34. Regulation of oligodendrocyte development and CNS myelination by growth factors: Prospects for therapy of demyelinating disease
35. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord
36. Central nervous system remyelination clinical application of basic neuroscience principles
37. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord
38. The alternative-splice isoforms of the PDGF A-chain differ in their ability to associate with the extracellular matrix and to bind heparin in vitro
39. Multiple cholinergic differentiation factors are present in footpad extracts: Comparison with cholinergic factors
40. Macrophage-derived growth factors
41. In vivo proliferation of oligodendrocyte progenitors expressing PDGF-αR during early remyelination
42. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation
43. Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue
44. Differential expression of insulin-like growth factor genes in rat central nervous system
45. Age-related activation of microglia and astrocytes: In vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation
46. Therapeutic strategies in multiple sclerosis. II. Long-term repair
47. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis
48. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination
49. Developing oligodendroglia express mRNA for insulin-like growth factor-I, a regulator of oligodendrocyte development
50. The re-expression of the homeodomain transcription factor Gtx during remyelination of experimentally induced demyelinating lesions in young and old rat brain
51. Endogenous aFGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: Immunohistochemical study
52. Effect of macrophage inactivation on the neuropathology of lysolecithin-induced demyelination
53. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty
54. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells
55. Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitors to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells
56. Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells
57. Growth factors and remyelination in the CNS
58. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide and complement/anti-galactocerebroside - A comparative study
59. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination
60. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis
61. Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during myelin regeneration
62. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice